Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 15 Jul 2021 |
10 | Journal Copy | 16 Apr 2024 |
11 | Certificate | 09 Jun 2024 |
2 | Reply to Exam Report (MIS-R) | 31 Aug 2021 |
3 | Authorization Letter | 16 May 2023 |
4 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 16 May 2023 |
5 | Documents in support of Show cause Hearing (SCH) | 30 May 2023 |
6 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 03 Jul 2023 |
7 | Documents in support of Show cause Hearing (SCH) | 20 Oct 2023 |
8 | Authorization Letter | 25 Oct 2023 |
9 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 22 Dec 2023 |
1 | EXAMINATION REPORT | 11946310 | 05 Aug 2021 | |
2 | Hearing Notice (Show Cause) | 13848734 | 27 Jul 2022 | |
3 | Hearing Notice (Show Cause) | 14682226 | 23 Jan 2023 | |
4 | Hearing Notice (Show Cause) | 15114420 | 18 Apr 2023 | |
5 | Hearing Notice (Show Cause) | 16111705 | 25 Sep 2023 | |
6 | Hearing Notice (Show Cause) | 16804997 | 13 Dec 2023 | |
7 | Tribunal Accepted Notice for : 5044937 | 16910694 | 6407351 | 22 Dec 2023 |
Trademark was applied on 15 July 2021 with IP India.
Proprietor of Hivfind is MERIL DIAGNOSTICS.
Class(es) in which the trademark was applied to is 10.
Status of Hivfind is Registered.
Application number alloted to the trademark is 5044937.
Anand & Anand is the Trademark agent/attorney.
Trademark has been filed in the following category:
WORD